Your session is about to expire
← Back to Search
Teriflunomide for Pediatric Multiple Sclerosis (TERIKIDS Trial)
TERIKIDS Trial Summary
This trial is testing whether the drug teriflunomide can help treat multiple sclerosis in children and adolescents. The trial will compare teriflunomide to a placebo, and will measure disease activity, brain MRI changes, and cognitive function.
TERIKIDS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 1001 Patients • NCT01895335TERIKIDS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My condition worsened again less than 30 days ago.I am between 10 and 18 years old.I have recently been treated with specific MS medications or immune system therapies.I am a woman able to have children and am not using strong birth control.My condition has worsened at least once in the past year or twice in the past two years.I have a history of HIV infection.My disability score is over 5.5.
- Group 1: Placebo
- Group 2: Teriflunomide
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Have medical researchers conducted this type of trial before?
"Genzyme, a subsidiary of Sanofi, first researched Teriflunomide in 2014. After the Phase 1 study concluded that year with 166 participants, the drug was approved for further testing in Phase 3 trials. As of now, there are 13 ongoing studies involving Teriflunomide across 323 cities and 62 countries."
Could you tell me how many research facilities are currently conducting this trial?
"There are 10 sites conducting this clinical trial currently. A few locations include Calgary, Cullman and Boston with other centres located throughout. If you are considering participating in the study, please choose the clinic that is closest to your residence to minimize travel time and effort."
Has Teriflunomide been given the green light by the FDA?
"Teriflunomide has been studied in prior clinical trials and shown to be safe, so it received a score of 3."
How can I become a part of this experiment?
"This clinical trial, which will enroll 166 patients, is for children and adolescents between the ages of 10-17 who have multiple sclerosis."
Are patients still being enrolled in this research project?
"Unfortunately, this specific study is not presently looking for candidates according to the clinicaltrials.gov website. Although 576 other trials are actively recruiting patients right now, this particular trial was last updated on June 15th, 2022 and is no longer seeking participants."
How many study participants are receiving treatment?
"Unfortunately, this study is not currently recruiting new participants. Having said that, it's worth noting that the date of the last edit was June 15th, 2022. There are 563 other trials for multiple sclerosis and 13 for Teriflunomide enrolling patients as we speak."
Are adults of age eligible for this research project?
"This clinical trial is looking for paediatric patients that are between 10 to 17 years old."
Are there other studies that have looked at Teriflunomide's effects?
"Teriflunomide was first evaluated in 2014 at Site 056001. Since then, there have been a total of 18314 completed studies investigating this medication. As of now, there are 13 active clinical trials underway. A large majority of these are located in Calgary, Alabama."
Share this study with friends
Copy Link
Messenger